Search Results for compound

Searching compound for 3,5,6 trimethyl 1,2 heptadien 4 one returned 21751 results.

Displaying compounds 10951 - 10975 of 21751 in total

(2-{[2-(hexadec-1-en-1-yloxy)-3-(pentadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

Matched description: … PC(15:0/P-16:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one ... PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment …

FDB025219

PC(16:1(9Z)/P-18:0)

(2-{[3-(hexadec-9-enoyloxy)-2-(octadec-1-en-1-yloxy)propyl phosphono]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... one chain of plasmalogen 18:0 at the C-2 position. ... PC(16:1(9Z)/P-18:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and …

FDB025349

PC(18:2(9Z,12Z)/P-16:0)

(2-{[2-(hexadec-1-en-1-yloxy)-3-(octadeca-9,12-dienoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... one chain of plasmalogen 16:0 at the C-2 position. ... PC(18:2(9Z,12Z)/P-16:0), in particular, consists of one chain of linoleic acid at the C-1 position and …

FDB025483

PC(20:0/P-18:1(11Z))

(2-{[3-(icosanoyloxy)-2-(octadeca-1,11-dien-1-yloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... one chain of plasmalogen 18:1n7 at the C-2 position. ... PC(20:0/P-18:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and …

FDB025516

PC(20:1(11Z)/P-18:1(11Z))

(2-{[3-(icos-11-enoyloxy)-2-(octadeca-1,11-dien-1-yloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... and one chain of plasmalogen 18:1n7 at the C-2 position. ... PC(20:1(11Z)/P-18:1(11Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position …

FDB025612

PC(20:3(8Z,11Z,14Z)/P-16:0)

(2-{[2-(hexadec-1-en-1-yloxy)-3-(icosa-8,11,14-trienoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... position and one chain of plasmalogen 16:0 at the C-2 position. ... PC(20:3(8Z,11Z,14Z)/P-16:0), in particular, consists of one chain of homo-g-linolenic acid at the C-1 …

FDB025615

PC(20:3(8Z,11Z,14Z)/P-18:1(9Z))

(2-{[3-(icosa-8,11,14-trienoyloxy)-2-(octadeca-1,9-dien-1-yloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. ... PC(20:3(8Z,11Z,14Z)/P-18:1(9Z)), in particular, consists of one chain of homo-g-linolenic acid at the …

FDB025744

PC(22:0/P-16:0)

(2-{[3-(docosanoyloxy)-2-(hexadec-1-en-1-yloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PC(22:0/P-16:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain ... PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment …

FDB025809

PC(22:2(13Z,16Z)/P-16:0)

(2-{[3-(docosa-13,16-dienoyloxy)-2-(hexadec-1-en-1-yloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... and one chain of plasmalogen 16:0 at the C-2 position. ... PC(22:2(13Z,16Z)/P-16:0), in particular, consists of one chain of docosadienoic acid at the C-1 position …

FDB025908

PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-16:0)

(2-{[3-(docosa-7,10,13,16,19-pentaenoyloxy)-2-(hexadec-1-en-1-yloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. ... PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-16:0), in particular, consists of one chain of docosapentaenoic acid at …

FDB025909

PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:0)

(2-{[3-(docosa-7,10,13,16,19-pentaenoyloxy)-2-(octadec-1-en-1-yloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. ... PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:0), in particular, consists of one chain of docosapentaenoic acid at …

FDB027958

PC(P-16:0/14:0)

(2-{[(2R)-3-(hexadec-1-en-1-yloxy)-2-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PC(P-16:0/14:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one ... PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment …

FDB027974

PC(P-16:0/20:3(8Z,11Z,14Z))

(2-{[3-(hexadec-1-en-1-yloxy)-2-(icosa-8,11,14-trienoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... and one chain of homo-g-linolenic acid at the C-2 position. ... PC(P-16:0/20:3(8Z,11Z,14Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position …

FDB027985

PC(P-16:0/24:0)

(2-{[3-(hexadec-1-en-1-yloxy)-2-(tetracosanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PC(P-16:0/24:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one ... PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment …

FDB028049

PC(P-18:1(9Z)/16:1(9Z))

(2-{[(2R)-2-(hexadec-9-enoyloxy)-3-(octadeca-1,9-dien-1-yloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... and one chain of palmitoleic acid at the C-2 position. ... PC(P-18:1(9Z)/16:1(9Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position …

FDB028060

PC(P-18:1(9Z)/20:3(5Z,8Z,11Z))

(2-{[(2R)-2-(icosa-5,8,11-trienoyloxy)-3-(octadeca-1,9-dien-1-yloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... position and one chain of mead acid at the C-2 position. ... PC(P-18:1(9Z)/20:3(5Z,8Z,11Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 …

FDB028066

PC(P-18:1(9Z)/22:1(13Z))

(2-{[(2R)-2-(docos-13-enoyloxy)-3-(octadeca-1,9-dien-1-yloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... and one chain of erucic acid at the C-2 position. ... PC(P-18:1(9Z)/22:1(13Z)), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position …

FDB028069

PC(P-18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))

(2-{[(2R)-2-(docosa-4,7,10,13,16-pentaenoyloxy)-3-(octadeca-1,9-dien-1-yloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

Matched description: … PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. ... the C-1 position and one chain of docosapentaenoic acid at the C-2 position. ... PC(P-18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)), in particular, consists of one chain of plasmalogen 18:1n9 at …

FDB108468

TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))

(2S)-1-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyloxy]-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate

Matched name: … TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)) …

FDB108469

TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))

(2S)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

Matched name: … TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) …

FDB108537

TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))

(2S)-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyloxy]-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate

Matched name: … TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)) …

FDB109973

TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))

(2R)-1-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyloxy]propan-2-yl (13Z,16Z)-docosa-13,16-dienoate

Matched name: … TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)) …

FDB109974